Pro Medicus Forecast, price target & analysts
Pro Medicus Target price 2026 - Analyst rating & recommendation
Pro Medicus Classifications & Recommendation
Pro Medicus Price Target
| Target Price | A$229.50 |
| Price | A$163.76 |
| Potential |
40.14%
register free of charge
|
| Number of Estimates | 15 |
|
15 Analysts have issued a price target Pro Medicus 2027 .
The average Pro Medicus target price is A$229.50.
This is
40.14%
register free of charge
A$262.50
60.30%
register free of charge
A$128.27
21.67%
register free of charge
|
|
| A rating was issued by 18 analysts: 12 Analysts recommend Pro Medicus to buy, 6 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Pro Medicus stock has an average upside potential 2027 of
40.14%
register free of charge
|
Sales and Margin forecast 2027, 2028 to 2033
| Jun '26 |
2027 Estimates |
|
|---|---|---|
| Revenue Million A$ | 270.75 | 341.82 |
| 22.77% | 26.25% | |
| EBITDA Margin | 78.76% | 78.80% |
| 0.70% | 0.05% | |
| Net Margin | 98.00% | 57.06% |
| 87.58% | 41.78% |
16 Analysts have issued a sales forecast Pro Medicus 2027 . The average Pro Medicus sales estimate is
This results in the following potential growth metrics:
16 Analysts have issued an Pro Medicus EBITDA forecast 2027. The average Pro Medicus EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
16 Pro Medicus Analysts have issued a net profit forecast 2027. The average Pro Medicus net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 to 2033
| Jun '26 |
2027 Estimates |
|
|---|---|---|
| Earnings Per Share A$ | 2.54 | 1.87 |
| 130.91% | 26.38% | |
| P/E | 86.85 | |
| EV/Sales | 48.48 |
16 Analysts have issued a Pro Medicus forecast for earnings per share. The average Pro Medicus EPS is
This results in the following potential growth metrics and future valuations:
Current Pro Medicus Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BELL POTTER SECURITIES |
Locked
➜
Locked
|
Locked | Sep 22 2026 |
| MACQUARIE RESEARCH |
Locked
➜
Locked
|
Locked | Aug 20 2026 |
| MOELIS AUSTRALIA SECURITIES |
Locked
➜
Locked
|
Locked | Aug 19 2026 |
| CANACCORD GENUITY |
Locked
➜
Locked
|
Locked | Aug 19 2026 |
| JEFFERIES |
Locked
➜
Locked
|
Locked | Jul 22 2026 |
| BELL POTTER SECURITIES |
Locked
➜
Locked
|
Locked | Jul 02 2026 |
| BELL POTTER SECURITIES |
Locked
➜
Locked
|
Locked | Jul 01 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
BELL POTTER SECURITIES:
Locked
➜
Locked
|
Sep 22 2026 |
|
Locked
MACQUARIE RESEARCH:
Locked
➜
Locked
|
Aug 20 2026 |
|
Locked
MOELIS AUSTRALIA SECURITIES:
Locked
➜
Locked
|
Aug 19 2026 |
|
Locked
CANACCORD GENUITY:
Locked
➜
Locked
|
Aug 19 2026 |
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Jul 22 2026 |
|
Locked
BELL POTTER SECURITIES:
Locked
➜
Locked
|
Jul 02 2026 |
|
Locked
BELL POTTER SECURITIES:
Locked
➜
Locked
|
Jul 01 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
